James Garner, Chief Executive Officer at Kazia Therapeutics Ltd, holds 52.50M shares in Percheron Therapeutics (Ticker: PERCF), holds 781.82K shares in Kazia Therapeutics Ltd (Ticker: DE:NV9). Most recently, James Garner Bought ― shares of Percheron Therapeutics on Jul 01, 2025 for an estimated value of 25.00K.
What is the percentage of profitable transactions made by James Garner?
The percentage of profitable transactions made by James Garner is ―.
What is the average return per transaction made by James Garner?
The average return per transaction made by James Garner is ―.
What stocks does James Garner hold?
James Garner holds: DE:NV9, PERCF stocks.
What was James Garner’s latest transaction?
James Garner latest transaction was an Informative Buy of $25.00K.
What was James Garner's most profitable transaction?
James Garner’s most profitable transaction was an Informative Buy of PERCF stock on November 20, 2023. The return on the trade was -16.00%.
What is James Garner's role in Kazia Therapeutics Ltd?
James Garner's role in Kazia Therapeutics Ltd is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.